Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
natural killer cells
Biotech
ARPA-H goes all in on in vivo cell therapy
One of the grant winners is a newly emerged biotech called ImmunoVec, which debuted with up to $40.7 million in funding from ARPA-H.
Darren Incorvaia
Oct 8, 2025 4:04pm
Gilead's Kite erodes $2.3B Shoreline cell therapy deal
Sep 3, 2025 3:18pm
CEO invests own cash to move NKGen toward Alzheimer’s readout
May 8, 2025 10:22am
Innate antibody pits NK cells against lymphoma in animal models
Nov 15, 2024 2:00pm
MD Anderson launches cell therapy institute with $80M
Nov 11, 2024 4:20pm
Artiva plans IPO to fund NK cell therapy's autoimmune trials
Jul 1, 2024 7:48am
